JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
PUT
Tyson Foods
TSN
$18.3B
| $1.9M | ﹤0.01% |
22,100
-18,000
| -45% | -$1.61M |
2021 Q3
3 quarters
|
|
3427
CALL
The Kraft Heinz Company
KHC
$26.3B
| $1.9M | ﹤0.01% |
49,800
-42,800
| -46% | -$1.71M |
2020 Q2
8 quarters
|
|
|
CMRC
3428
Commerce.com Inc Series 1
CMRC
$269M
| $1.9M | ﹤0.01% |
117,196
-73,977
| -39% | -$1.35M |
2020 Q3
7 quarters
|
|
3429
GrafTech
EAF
$246M
| $1.89M | ﹤0.01% |
26,777
-36,214
| -57% | -$3.15M |
2018 Q2
16 quarters
|
|
|
HHLA.U
3430
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
| $1.89M | ﹤0.01% |
+191,864
| New | +$1.9M |
2022 Q2
0 quarters
|
|
|
ABTX
3431
DELISTED
Allegiance Bancshares
ABTX
| $1.88M | ﹤0.01% |
49,870
+40,620
| +439% | +$1.63M |
2016 Q1
25 quarters
|
|
|
CVAC
3432
DELISTED
CureVac
CVAC
| $1.88M | ﹤0.01% |
138,229
+115,412
| +506% | +$1.91M |
2020 Q4
6 quarters
|
|
3433
Altimmune
ALT
$532M
| $1.88M | ﹤0.01% |
160,573
-147,016
| -48% | -$907K |
2020 Q4
6 quarters
|
|
|
TBPH
3434
DELISTED
Theravance Biopharma
TBPH
| $1.88M | ﹤0.01% |
207,355
+34,063
| +20% | +$314K |
2015 Q4
26 quarters
|
|
|
BMAQ
3435
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
| $1.88M | ﹤0.01% |
+190,000
| New | +$1.88M |
2022 Q2
0 quarters
|
|
|
SABRP
3436
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
| $1.87M | ﹤0.01% |
23,500
-11,033
| -32% | -$1.17M |
2021 Q4
2 quarters
|
|
3437
Pitney Bowes
PBI
$2.3B
| $1.87M | ﹤0.01% |
516,433
+296,917
| +135% | +$1.35M |
2013 Q2
36 quarters
|
|
3438
Allegiant Air
ALGT
$2.12B
| $1.86M | ﹤0.01% |
16,496
-19,010
| -54% | -$2.74M |
2015 Q1
29 quarters
|
|
3439
PUT
Marriott Vacations Worldwide
VAC
$3.58B
| $1.86M | ﹤0.01% |
+16,000
| New | +$2.25M |
2022 Q2
0 quarters
|
|
|
WW
3440
DELISTED
WW International
WW
| $1.86M | ﹤0.01% |
290,896
+172,289
| +145% | +$1.45M |
2016 Q2
24 quarters
|
|
3441
PUT
ASML
ASML
$717B
| $1.86M | ﹤0.01% |
3,900
+1,500
| +63% | +$837K |
2022 Q1
1 quarter
|
|
3442
Palomar
PLMR
$3.33B
| $1.85M | ﹤0.01% |
28,815
+17,133
| +147% | +$1.03M |
2019 Q2
12 quarters
|
|
|
ARI
3443
Apollo Commercial Real Estate
ARI
$797M
| $1.85M | ﹤0.01% |
177,326
-223,166
| -56% | -$2.74M |
2013 Q2
36 quarters
|
|
3444
Arqit Quantum
ARQQ
$428M
| $1.85M | ﹤0.01% |
11,738
+11,737
| +1,173,700% | +$2.43M |
2022 Q1
1 quarter
|
|
3445
Nicolet Bankshares
NIC
$3.49B
| $1.85M | ﹤0.01% |
25,522
-15,070
| -37% | -$1.22M |
2017 Q4
18 quarters
|
|
|
RNAM
3446
DELISTED
Avidity Biosciences
RNAM
| $1.84M | ﹤0.01% |
126,582
+25,467
| +25% | +$379K |
2020 Q3
7 quarters
|
|
3447
Carpenter Technology
CRS
$19.3B
| $1.84M | ﹤0.01% |
65,864
-59,939
| -48% | -$2.13M |
2013 Q2
36 quarters
|
|
3448
OrthoPediatrics
KIDS
$579M
| $1.84M | ﹤0.01% |
42,612
+36,063
| +551% | +$1.65M |
2017 Q4
18 quarters
|
|
3449
CALL
Yum! Brands
YUM
$37.1B
| $1.84M | ﹤0.01% |
+16,200
| New | +$1.88M |
2022 Q2
0 quarters
|
|
3450
Stem
STEM
$41M
| $1.84M | ﹤0.01% |
12,826
+7,805
| +155% | +$1.3M |
2021 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.